Clinical Trial Update: Effect of Pioglitazone on Insulin Resistance and Atherosclerosis in Renal Allograft Recipients Without Diabetes [NA]

View source ↗

Summary

Clinical trial update on pioglitazone for insulin resistance and atherosclerosis in renal allograft recipients without diabetes. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Insulin Resistance

Drugs mentioned

• PIOGLITAZONE (Pioglitazone)

Snippet

Sponsor: Yonsei University | Conditions: Kidney Transplantation, Insulin Resistance | NA | Status: COMPLETED